for-phone-onlyfor-tablet-portrait-upfor-tablet-landscape-upfor-desktop-upfor-wide-desktop-up

Allakos Inc

ALLK.OQ

現在値

6.85USD

変化

-0.33(-4.60%)

出来高

587,670

本日のレンジ

6.81

 - 

7.42

52週レンジ

6.81

 - 

157.62

∙ 約20分前の相場を表示しています。

適時開示

Allakos Says Topline Phase 3 Data From The Enigma 2 Study And Phase 2/3 Data From The Kryptos Study In Patients With Eosinophilic Gastrointestinal Diseases

Dec 21 (Reuters) - Allakos Inc <ALLK.O>::ALLAKOS ANNOUNCES TOPLINE PHASE 3 DATA FROM THE ENIGMA 2 STUDY AND PHASE 2/3 DATA FROM THE KRYPTOS STUDY IN PATIENTS WITH EOSINOPHILIC GASTROINTESTINAL DISEASES.BOTH ENIGMA 2 AND KRYPTOS STUDIES MET THEIR HISTOLOGIC CO-PRIMARY ENDPOINTS.BOTH STUDIES DID NOT ACHIEVE STATISTICAL SIGNIFICANCE ON PATIENT REPORTED SYMPTOMATIC CO-PRIMARY ENDPOINTS.

Allakos Announces Expansion Of Lirentelimab Development Into Atopic Dermatitis, Chronic Spontaneous Urticaria And Asthma

Nov 30 (Reuters) - Allakos Inc <ALLK.O>::ALLAKOS ANNOUNCES EXPANSION OF LIRENTELIMAB DEVELOPMENT INTO ATOPIC DERMATITIS, CHRONIC SPONTANEOUS URTICARIA AND ASTHMA.ALLAKOS INC - PHASE 2 ATOPIC DERMATITIS TRIAL OF SUBCUTANEOUS LIRENTELIMAB INITIATED.ALLAKOS INC - PHASE 2/3 CHRONIC SPONTANEOUS URTICARIA TRIAL OF SUBCUTANEOUS LIRENTELIMAB TO BEGIN IN MID 2022.ALLAKOS INC - PHASE 2 ASTHMA TRIAL OF SUBCUTANEOUS LIRENTELIMAB TO BEGIN IN Q4 2022.

Allakos Reports Third Quarter 2021 Financial Results

Nov 8 (Reuters) - Allakos Inc <ALLK.O>::ALLAKOS PROVIDES BUSINESS UPDATE AND REPORTS THIRD QUARTER 2021 FINANCIAL RESULTS.Q3 LOSS PER SHARE $1.16.

Allakos Provides Business Update And Reports Second Quarter 2021 Financial Results

Aug 9 (Reuters) - Allakos Inc <ALLK.O>::ALLAKOS PROVIDES BUSINESS UPDATE AND REPORTS SECOND QUARTER 2021 FINANCIAL RESULTS.Q2 LOSS PER SHARE $1.07.Q2 EARNINGS PER SHARE ESTIMATE $-1.06 -- REFINITIV IBES DATA.ENDED Q2 OF 2021 WITH $559.7 MILLION IN CASH, CASH EQUIVALENTS AND MARKETABLE SECURITIES.

Allakos Posts Q1 Loss Per Share Of $1.04

May 10 (Reuters) - Allakos Inc <ALLK.O>::ALLAKOS REPORTS FIRST QUARTER 2021 FINANCIAL RESULTS AND PROVIDES BUSINESS UPDATE.Q1 LOSS PER SHARE $1.04.Q1 EARNINGS PER SHARE ESTIMATE $-0.88 -- REFINITIV IBES DATA.

Allakos Reports Fourth Quarter And Full Year 2020 Financial Results And Provides Business Update

March 1 (Reuters) - Allakos Inc <ALLK.O>::ALLAKOS REPORTS FOURTH QUARTER AND FULL YEAR 2020 FINANCIAL RESULTS AND PROVIDES BUSINESS UPDATE.Q4 LOSS PER SHARE $0.86.Q4 EARNINGS PER SHARE ESTIMATE $-0.86 -- REFINITIV IBES DATA.

Allakos Reports Q3 Loss Per Share Of $0.86

Nov 9 (Reuters) - Allakos Inc <ALLK.O>::ALLAKOS REPORTS THIRD QUARTER 2020 FINANCIAL RESULTS AND PROVIDES BUSINESS UPDATE.Q3 LOSS PER SHARE $0.86.Q3 EARNINGS PER SHARE ESTIMATE $-0.82 -- REFINITIV IBES DATA.

Allakos Offers 3,048,781 Shares At Public Offering Price Of $82.00 Per Share

Oct 28 (Reuters) - Allakos Inc <ALLK.O>::ALLAKOS ANNOUNCES PRICING OF PUBLIC OFFERING OF COMMON STOCK.IS OFFERING 3,048,781 SHARES AT A PUBLIC OFFERING PRICE OF $82.00 PER SHARE.

Allakos Expects Qtrly Net Loss Between $40.0 Mln And $50.0 Mln

Oct 27 (Reuters) - Allakos Inc <ALLK.O>::ALLAKOS PREVIEWS PRELIMINARY FINANCIAL RESULTS FOR THE THREE MONTHS ENDED SEPTEMBER 30, 2020.EXPECTS NET LOSS WILL BE BETWEEN $40.0 MILLION AND $50.0 MILLION FOR THREE MONTHS ENDED SEPTEMBER 30, 2020.ESTIMATES THAT CASH, CASH EQUIVALENTS AND INVESTMENTS IN MARKETABLE SECURITIES WILL BE $419.8 MILLION AS OF SEPTEMBER 30, 2020.

Allakos Announces Proposed Public Offering Of Common Stock

Oct 27 (Reuters) - Allakos Inc <ALLK.O>::ALLAKOS ANNOUNCES PROPOSED PUBLIC OFFERING OF COMMON STOCK.ALLAKOS INC - INTENDS TO OFFER AND SELL $250 MILLION OF SHARES OF ITS COMMON STOCK IN UNDERWRITTEN PUBLIC OFFERING.

金融情報はリフィニティブから。すべての情報は少なくとも20分遅れで表示されています。

for-phone-onlyfor-tablet-portrait-upfor-tablet-landscape-upfor-desktop-upfor-wide-desktop-up